As observed in HCC and prostate cancer, the formation of the MT1h-GLP complex is critical for the MT1h tumor-suppressive effect, as a mutation in MT1h inhibits GLP binding and abolishes the tumor-suppressive activity of MT1h [158]. This evidence concerns the gene MT1H and Familial prostate cancer.